7 medtech stories we missed this week: August 3, 2018

[Image from unsplash.com]From Esaote launching its new ultrasound device to Nipro’s Infraredx launching in Japan, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. Esaote launches new ultrasound devices Esaote announced in an Aug. 2 press release that it has launched its new MyLab X7, MyLab X6 and MyLab X5 ultrasound systems. The MyLab X7 offers faster and more reliable ultrasounds with intuitive usability and ergonomics. MyLab X5 has zero-click automatic that speeds up assessments and enhances image quality. 2. Bonesupport inks deal with MTF Biologics Bonesupport and MTF Biologics have signed an agreement to extend and strengthen Bonesupport’s product offerings in the U.S., according to an Aug. 2 press release. Bonesupport will receive rights to two forms of bone graft materials that are made from 100% demineralized bone matrix. The products supplied by MTF Biologics will be launched under the Bonesupport name through its own U.S. distribution network. 3. Canada approves Mindshare Medical’s lung cancer diagnosis software Mindshare Medical announced in an Aug. 2 press release that it has received Health Canada approval for its RevealAI-Lung product. The product is a computer-assisted diagnostic software program for lung cancer diagnosis. It helps clinicians improve diagnostic efficacy while optimizing recommendations for follow-up. The technology uses a radiomics approach that generates a malignancy...
Source: Mass Device - Category: Medical Devices Authors: Tags: 510(k) Catheters Diagnostics Food & Drug Administration (FDA) Hospital Care Imaging Regulatory/Compliance Software / IT Ultrasound Bonesupport Esaote InfraReDx Inc. ivwatch MedTech Mindshare Medical Modulated Imaging MTF Bi Source Type: news

Related Links:

Publication date: Available online 20 October 2019Source: European Journal of RadiologyAuthor(s): Chuqian Lei, Wei Wei, Zhenyu Liu, Qianqian Xiong, Ciqiu Yang, Mei Yang, Liulu Zhang, Teng Zhu, Xiaosheng Zhuang, Chunling Liu, Zaiyi Liu, Jie Tian, Kun WangAbstractPurposeWe developed and validated a radiomic model based on mammography and assessed its value for predicting the pathological diagnosis of Breast Imaging Reporting and Data System (BI-RADS) category 4 calcifications.Materials and MethodsPatients with a total of 212 eligible calcifications were recruited (159 cases in the primary cohort and 53 cases in the validatio...
Source: European Journal of Radiology - Category: Radiology Source Type: research
Conversations and healthy debate about issues facing our industry and the health care system are critical to addressing some of today ’s challenges and opportunities. The Catalyst welcomes guest contributors, including patients, stakeholders, innovators and others, to share their perspectives and point of view. Views represented here may not be those of PhRMA, though they are no less key to a healthy dialogue on issues in health care today.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: diabetes Out of Pocket Costs Voters for Cures Source Type: news
ConclusionsThe relevance of SPARC expression in pancreato-biliary carcinomas though may still be important for therapeutic decision making, it is not responsible for peritumoral stromal desmoplasia in these tumors and it does not have any significant prognostic implication.
Source: Pathology Research and Practice - Category: Pathology Source Type: research
Objective: To compare the rate of malreduction after high fibular fractures associated with syndesmosis injury treated with open reduction and internal fixation, with either 2 screws or 1 knotless TightRope device. Design: Prospective randomized controlled multicenter trial. Setting: Eleven academic and community hospitals including Level 1 and Level 2 trauma centers across Canada. Patients/Participants: One hundred three patients with OTA/AO 44-C injuries with demonstrated radiographic syndesmosis diastasis or instability after malleolar bony fixation were followed for 12 months after treatment. Methods: Ope...
Source: Journal of Orthopaedic Trauma - Category: Orthopaedics Tags: Original Article Source Type: research
Source: BMJ Comments - Category: General Medicine Source Type: forums
Publication date: Available online 20 October 2019Source: The LancetAuthor(s): Daniel I Sessler, Lijian Pei, Yuguang Huang, Edith Fleischmann, Peter Marhofer, Andrea Kurz, Douglas B Mayers, Tanja A Meyer-Treschan, Martin Grady, Ern Yu Tan, Sabry Ayad, Edward J Mascha, Donal J Buggy, Gang Tan, Zhiyong Zhang, Helen Keane, Maurice Stokes, Oliver Zotti, Michael Gnant, Silvia Perez-ProttoSummaryBackgroundThree perioperative factors impair host defence against recurrence during cancer surgery: the surgical stress response, use of volatile anaesthetic, and opioids for analgesia. All factors are ameliorated by regional anaesthesia...
Source: The Lancet - Category: General Medicine Source Type: research
Swedish researchers used ultrasound to discover that athletes who are more...Read more on AuntMinnie.comRelated Reading: MRI provides unique views of youth concussion Studies question link between contact sports and CTE Soccer ball heading more risky for women than men 3D knee model reveals ACL tear same in men, women MRI won gold at 2016 Rio Summer Olympics
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
Sometime during the 90s, I listened to an audio program that explained the differences between matchers and mismatchers.Matchers are “yes, and” people who see the upsides of an idea more prominently than the downsides. If you share a new idea with them, they’ll see how the idea could work and may offer suggestions for what else you could do to make it even better.Mismatchers are “wait, but” people who see the downsides of an idea more prominently than the upsides. If you share a new idea with them, they see what could go wrong and may point out the risks and drawbacks.I’m a matcher. I fi...
Source: Steve Pavlina's Personal Development Blog - Category: Psychiatry & Psychology Authors: Tags: Productivity Source Type: blogs
The latest crowdfunded research project undertaken by the SENS Research Foundation involves using the genetically engineered maximally modifiable mouse lineage in order to demonstrate the ability to copy a version of the ATP8 mitochondrial gene into the cell nucleus, a process known as allotopic expression, and thus prevent mutational damage to this gene from degrading mitochondrial function. This is a modest step on the road towards bringing this class of genetic engineering project to the point of readiness for commercial development, when a biotech startup company could be created to carry it forward. In just a f...
Source: Fight Aging! - Category: Research Authors: Tags: Activism, Advocacy and Education Source Type: blogs
CCR Grand Rounds Dr. Jabado ’ s research focuses on elucidating genetic signatures of pediatric astrocytomas and examining how they compare to adults. These are deadly brain tumors that originate in the brain and include glioblastomas (GBM, the highest grade of astrocytomas), which are one of the deadliest cancers in humans. Her group uncovered that pediatric high-grade astrocytomas (HGA) are molecularly and genetically distinct from adult tumors. They also identified a new molecular mechanism driving pediatric HGA, namely recurrent somatic driver mutations in the tail of histone 3 variants (H3.3 and H3.1). These mut...
Source: Videocast - All Events - Category: General Medicine Tags: Upcoming Events Source Type: video
More News: Bone Graft | Burns | Canada Health | Cancer | Cancer & Oncology | Computers | Databases & Libraries | Diabetes | Diabetic Ulcers | Endocrinology | Endoscopy | Hospitals | Japan Health | Lung Cancer | Medical Devices | Men | Skin | Skin Graft | Ultrasound